Wound Care News and Research

RSS

PuriCore sales decreases 9.9% to $10.0 million for first-quarter 2010

PuriCore, the water-based clean technology company focused on developing and commercializing proprietary, green solutions that safely, effectively, and naturally kill infectious pathogens, today issued its Interim Management Statement covering the period January 1, 2010, to March 31, 2010.

28 May 2010

PuriCore revenue increases 28% to $40.0 million for year ending December 31, 2009

PuriCore, the water-based clean technology company focused on developing and commercializing proprietary, green solutions that safely, effectively, and naturally kill infectious pathogens, today announced its Final Results for the year ending December 31, 2009, and the availability of its 2009 annual report on its website.

28 May 2010

KCI receives 510(k) clearance to market V.A.C. Therapy System for treatment of VLUs

Kinetic Concepts, Inc. announced today that it has received 510(k) clearance from the Food and Drug Administration to market its proprietary Vacuum Assisted Closure, or V.A.C. Therapy System, for the treatment of venous insufficiency ulcers, also known as venous leg ulcers.

28 May 2010

Quality Partners of Rhode Island equips healthcare providers with Pocket Guide to Pressure Ulcers

Quality Partners of Rhode Island, the state's Medicare Quality Improvement Organization, has equipped Ocean State nursing homes working to reduce pressure ulcers with copies of the Pocket Guide to Pressure Ulcers, a new reference resource.

28 May 2010

Kensey Nash granted FDA 510(k) clearance for Meso BioMatrix ECM product

Kensey Nash Corporation, a leading medical technology company that provides innovative resorbable biomaterial technology for a wide range of medical procedures, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration for its second extracellular matrix (ECM) product, the Meso BioMatrix™ product.

27 May 2010

Consequences of secrecy in medicine

No one knows how many mothers' and babies' lives have been saved by the obstetrical forceps. This device has been part of the standard equipment of every maternity room for about 250 years. However, a shadow lies over the success story: after the Chamberlen brothers developed the device at the beginning of the 17th century, the brothers and their descendants used it for 3 generations, but kept it a secret from other obstetricians.

26 May 2010

CoDa Therapeutics reports positive results from Phase 2 study of NEXAGON for chronic venous leg ulcers

CoDa Therapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of therapeutics for wound care and tissue repair, today announced positive results from its Phase 2 NOVEL Study of NEXAGON® in patients with chronic venous leg ulcers. NEXAGON® is a topically applied, novel therapeutic candidate, with the potential to revolutionize the wound healing treatment paradigm by leveraging a new mechanism and target involved in the healing process.

25 May 2010

BioLife Solutions first-quarter revenue up 36% to $513,000

BioLife Solutions, Inc., announced today that Chairman and Chief Executive Officer Mike Rice issued the following letter to shareholders providing a general corporate update.

20 May 2010

VNA receives grant award to enhance Wound Care Program

The Visiting Nurse Association of Greater Philadelphia has received a grant award from the First Hospital Foundation in the amount of $40,000. The grant will be used to enhance the VNA's Wound Care Program and will enable the agency to purchase digital cameras so the home visiting clinicians can document patients wound progression and improve wound care delivery.

15 May 2010

SANUWAVE Health reports $3.0 million net loss for first-quarter 2010

SANUWAVE Health, Inc.,, an emerging medical technology company focused on regenerative medicine, today reported financial results for the three months ended March 31, 2010 and provided a business update.

14 May 2010

ULURU reports net loss of $1.3M for first-quarter 2010

ULURU Inc. today announced its financial results for the first quarter ended March 31, 2010.

14 May 2010

Derma Sciences first-quarter net sales up 23% to $12,844,382

Derma Sciences, Inc., a specialty medical device/pharmaceutical company focused on advanced wound care, reported financial and operating results today for the three months ended March 31, 2010.

14 May 2010

RBC Life Sciences first-quarter net sales increase 16% to $7.0M

RBC Life Sciences, Inc., a provider of proprietary nutritional supplements, wound care and pain management products, today reported company-wide net sales of $7.0 million for the first quarter ended March 31, 2010, compared to net sales of $6.0 million for the same period during 2009, an increase of 16%.

12 May 2010

Derma Sciences adds XTRASORB Foam dressing to advanced wound care product portfolio

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, announced the launch of its new XTRASORB™ Foam dressing. The dressing is the company's first novel entry in the $300 million foam wound dressing market. First sales are expected during the second quarter of 2010.

4 May 2010

3M first-quarter worldwide sales up 25% to $6.3 billion

3M today reported first-quarter earnings of $1.29 per share on sales of $6.3 billion. Operating income margins were 22.8 percent, up 7 percentage points year-on-year. Sales and per-share earnings increased 24.7 percent and 74.3 percent, respectively, versus the first quarter of 2009.

27 Apr 2010

Kinetic Concepts' first-quarter 2010 total revenues increase 3% to $485.8M

Kinetic Concepts, Inc. today reported first quarter 2010 total revenue of $485.8 million, an increase of 3% from the first quarter of 2009. Foreign currency exchange movements favorably impacted total revenue for the first quarter of 2010 by 2% compared to the corresponding period of the prior year.

27 Apr 2010

American board-certified prosthetist develops custom-made ankle-foot orthosis

With over ten million diabetics in the U.S. alone and approximately 150,000 amputations performed yearly, inventor and American board-certified prosthetist John E. Rooney developed a custom-made ankle-foot orthosis with the trade name Ulcer Healing Orthosis or UHO.

26 Apr 2010

Kinetic Concepts introduces V.A.C.Via Therapy System

Kinetic Concepts, Inc. today introduced V.A.C.Via Therapy System, a next-generation negative pressure wound therapy solution that offers clinicians and patients a mobile healing technology with the proven benefits and outcomes of V.A.C. Therapy.

26 Apr 2010

Misonix signs exclusive distribution agreement with Suministros Medicos Multimedicas

Misonix, Inc., a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, has entered into a new, three year, exclusive distribution agreement with Suministros Medicos Multimedicas, based in Caracas, Venezuela, for the distribution of the SonaStar Ultrasonic Surgical Aspirator, the BoneScalpel Ultrasonic Bone Cutter, and the SonicOne Ultrasonic Wound Debrider.

24 Apr 2010

New book titled 'Advances in Wound Care' addresses major, escalating health problem

The publication of the new book Advances in Wound Care, addresses this major and escalating health problem. The first in an annual book series, Volume 1 strengthens the interdisciplinary continuum of wound care to synchronize the numerous disciplines the wound care community represents.

20 Apr 2010